CAPR - Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13 | Benzinga
SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the first quarter ended March 31, 2024, after the market close on Monday, May 13, 2024. Management will then host a webcast and conference call at 4:30 p.m. ET on May 13.
| Title: |
| Capricor Therapeutics First Quarter 2024 Financial Results and Recent Corporate Update Conference Call and Webcast |
| Date: |
| Monday, May 13, 2024 |
| Time: |
| 4:30 p.m. ET |
| Conference Call Details: |
| Toll-Free: 1-888-886-7786 International: 1-416-764-8658 Conference ID: 01529679 Participants can use guest dial-in numbers above and be answered by an operator or click the Call me™ link for instant telephone access to ... |